Precision Biosensor Inc
KOSDAQ:335810
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clearway Energy Inc
NYSE:CWEN.A
|
US |
|
Ningbo Shimao Energy Co Ltd
SSE:605028
|
CN |
Precision Biosensor Inc
Stock-Based Compensation
Precision Biosensor Inc
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Precision Biosensor Inc
KOSDAQ:335810
|
Stock-Based Compensation
₩46.6m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
84%
|
CAGR 10-Years
N/A
|
|
|
SD Biosensor Inc
KRX:137310
|
Stock-Based Compensation
₩905.4m
|
CAGR 3-Years
-64%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Stock-Based Compensation
₩66.4m
|
CAGR 3-Years
23%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Stock-Based Compensation
₩9.2B
|
CAGR 3-Years
38%
|
CAGR 5-Years
7%
|
CAGR 10-Years
24%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Precision Biosensor Inc
Glance View
Precision Biosensor, Inc. develops in-vitro diagnostics technology that provides advanced diagnostic solutions. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2020-12-22. The firm's main products include testers and cartridges. The testers are portable immunoassay diagnostic devices for on-site diagnosis that uses colorimetric and time-resolved fluorescence to check acute heart disease, metabolism, and inflammatory diseases. The cartridges are used in gold absorption and time-resolved fluorescence analysis diagnostic equipment, and can check acute heart disease, metabolism, and inflammatory diseases. The firm sells its products in domestic and overseas markets such as Europe, China, the Middle East, and Southeast Asia.
See Also
What is Precision Biosensor Inc's Stock-Based Compensation?
Stock-Based Compensation
46.6m
KRW
Based on the financial report for Dec 31, 2024, Precision Biosensor Inc's Stock-Based Compensation amounts to 46.6m KRW.
What is Precision Biosensor Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
84%
Over the last year, the Stock-Based Compensation growth was -70%. The average annual Stock-Based Compensation growth rates for Precision Biosensor Inc have been -14% over the past three years , 84% over the past five years .
